uBiome Investor

uBiome is a provider of public access to DNA sequencing technology to understand the microbiome.
Investors
Technology:
Early drug development
Industry:
Early Drug Development
Headquarters:
San Francisco, California, United States
Zip:
NA
Founded Date:
01.11.2012
Employees Number:
101-250
Funding Status:
Late Stage Venture
Acquisitions Number:
NA
Investors Number:
NA
Total Funding:
$110 M
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018-09-21
Last Funding Type:
Series C
Register and Claim Ownership